Biosimilars Market by Product Type (Monoclonal Antibodies, Insulins, Erythropoietin (EPO), Granulocyte-Colony Stimulating Factors (G-CSF), Hematopoietic Agents, Follitropin, and Others), by Manufacturing Approach (In-House Manufacturing and Contract Manufacturing), by Application (Oncology, Autoimmune Diseases, Diabetes, Hematology, Nephrology, and Endocrinology), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Opportunity Analysis and Industry Forecast, 2024–2030
